In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Country:  U.S.A.
Treatment/Intervention:  botanical therapy
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0706002781, ACS IRG 58-012-49, NCT00730158

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J1161, NCT01317199

3.

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: Application ID 213, NCT01585246

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0105-1012, NCT01820260

5.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 and over
Sponsor: NCI
Protocol IDs: MAYO-MC084C, MC084C, R01-CA-132991

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0105-1020, NCT01998984

9.

Phase: Phase I
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00014010, WCI1549-08, NCT01116336

10.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 10-089, NCT01239095

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: BCC-GI-10 Curcumin, NCT01294072

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LCCC 1227, NCT01859858

13.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NCI
Protocol IDs: NCI-2013-00536, CDR0000592794, NA_00011821, 00011821, R01-CA-134620, P30CA006973, NCT00641147

14.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI, Other
Protocol IDs: H08-081, 1R21CA137545-01A2, FWCC, NCT01160302

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: P01 CA090890, NCT01344330

16.

Phase: No phase specified
Type: Prevention
Status: Active
Age: 23 to 40
Sponsor: Other
Protocol IDs: 2007C0109, NCT01162642

17.

Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EH0524BlackCohosh, NCT01628536

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: I 211911, NCI-2012-01770, P30CA016056, K07CA148888, NCT01753908
New Search